Michael Dunne

Michael Dunne

Net worth: 12 026 $ as of 30/06/2026

67 year
Health Technology
Commercial Services
Consumer Services

Profile

Michael W.
Dunne
is the founder of Iterum Therapeutics Plc, serving as Director since 2020.
Current jobs include Vice Chairman at Antimicrobials Working Group since 2018, Director at Iterum Therapeutics International Ltd., and Chief Science Officer at Iterum Pharmaceuticals LLC.
Former jobs include Independent Non-Executive Director at Aviragen Therapeutics, Inc. from 2015 to 2018, VP & Head- Development for Infectious Disease at Pfizer Inc. from 2001 to 2009, Chief Medical Officer at Durata Therapeutics, Inc. from 2010 to 2014, Vice President-R&D at Allergan UC from 2014 to 2015, and Chief Scientific Officer at Gates Medical Research Institute from 2015 to 2020.
Memberships include American College of Physicians, Inc., Infectious Diseases Society of America, and American Society for Microbiology.
Education includes an undergraduate degree from Northwestern University and a doctorate from The State University of New York.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
30/11/2025 241,001 ( 0.46% ) 12 026 $ 30/06/2026

Michael Dunne active positions

CompaniesPositionStart
ITERUM THERAPEUTICS PLC Founder 01/11/2015
Chief Tech/Sci/R&D Officer -
Director/Board Member 30/01/2018
Director/Board Member -

Former positions of Michael Dunne

CompaniesPositionEnd
Director/Board Member 01/01/2018
ALLERGAN PLC Chief Tech/Sci/R&D Officer 01/09/2015
DURATA THERAPEUTICS INC Chief Tech/Sci/R&D Officer 01/11/2014
PFIZER INC. Chief Tech/Sci/R&D Officer 01/01/2009
Gates Medical Research Institute
Chief Tech/Sci/R&D Officer -
See the detail of Michael Dunne's experience

Training of Michael Dunne

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

98

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies14

Health Technology

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Gates Medical Research Institute

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!